Osteoarthritis Treatment Market By Type (Analgesics, Non-Steroidal Anti-Inflammatory Drugs (Nsaids), Corticosteroids, Hyaluronic Acid, Pipeline Analysis) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2022

This report on global osteoarthritis treatment market studies various type of therapeutics used for treatment of osteoarthritis along with pipeline analysis of upcoming potential drugs. Globally, osteoarthritis is the eighth leading cause of disability with the joint most frequently associated with disability being the knee. The current treatment available for osteoarthritis treatment is incapable due to lack of efficacy and serious side-effects associated with the long term use. Thus, drug pipeline of osteoporosis treatment market comprises potential drugs which possesses high efficacy, less side-effects and innovative properties. 

For the purpose of this study, the various therapeutics type considered are analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and hyaluronic acid. Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective CAGRs for the period 2016 to 2022, considering 2015 as the base year.

Osteoarthritis Treatment Market 

The pipeline analysis for osteoarthritis treatment market comprises projected market sales of Phase III drugs estimated till 2022. The phase III drugs included in the pipeline analysis are Sprifermin (Merck Serono), Invossa (TissueGene), Ampion (Ampio Pharmaceuticals. Inc.),Apitox (Apimeds, Inc.), Fasinumab (Regeneron Pharmaceuticals), LBSA0103 (LG Life Sciences), and AXS-02 (Axsome Therapeutics, Inc.). The report also covers qualitative information associated with the drugs under phase II and I of the clinical trials.

The geographic segmentation of the global osteoarthritis treatment market is performed for the regions North America, Europe, Asia Pacific and Rest of the World markets. The regions are also further sub-segmented on the basis of major countries. Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective CAGRs for the period 2016 to 2022, considering 2015 as the base year.

The key players covered in osteoarthritis treatment market are Abbott Laboratories, Johnson & Johnson Limited, Novartis AG, Pfizer, Inc., Abiogen Pharma Spa, Ampio Pharmaceuticals, BioDelivery Sciences International, Inc., Eli Lilly and Company, Merck & Co., Sanofi SA, and Smith & Nephew, Inc.

For the purpose of this study, the global osteoarthritis treatment market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Osteoarthritis Treatment Market

North America was observed as the largest market for osteoarthritis treatment in the base year 2015. According to Centers for Disease Control and Prevention (CDC), in 2015 the U.S. comprises 62% of adults with arthritis are

Choose License Type
Published Date:  May 2016
Category:  Pharmaceuticals
Report ID:   57819
Report Format:   PDF
Pages:   120
Rating:    4.3 (55)
Connect With Us
+1-408-641-3282
24/7 Research Support